Medical Devices Market
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
 |
Global Dermatology Treatment Devices Market Treatment Devices and Diagnostic Devices adds up to total |
May 2015 |
|
|
Intranasal Drug Delivery Systems Intranasal Drug Delivery Systems and Injectables Drug Delivery devices, |
Upcoming |
|
|
Global Transdermal Drug Delivery Systems Market The Global Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies on in-house capabilities for the development of oral drug delivery technologies.The Market was Valued at $13.5 billion in 2013 and expected to be $21.7 billion by 2018, growing at a CAGR of 11.1%. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven. |
Upcoming |
|
|
Stroboscope Stroboscope and Brachoscope, Laryngoscope, |
Upcoming |
|
|
Brachoscope Brachoscope and Stroboscope, Laryngoscope, |
Upcoming |
|
|
Laryngoscope Laryngoscope and Stroboscope, Brachoscope, |
Upcoming |
|
|
Otoscope Otoscope and Stroboscope, Brachoscope, |
Upcoming |
|
|
Nasopharyngoscope Nasopharyngoscope and Stroboscope, Brachoscope, |
Upcoming |
|
|
Pharyngoscope Pharyngoscope and Stroboscope, Brachoscope, |
Upcoming |
|
|
Microdebrider Microdebrider and Stroboscope, Brachoscope, |
Upcoming |
|
|
ENT Instruments ENT Instruments and Stroboscope, Brachoscope, |
Upcoming |
|
|
Neurointerventional Device Market The global Neurointerventional devices market is estimated to be $1544.79 million in 2013 and is expected to grow at a CAGR of 6.8% to reach $1944.7 million by 2018. The Neurointerventional Devices market segmentation by 5 segments such as neurothrombectomy devices (suction/aspiration device, clot retriever, and snare device), cerebral angiography and stenting system (carotid stent, and embolic protection system), aneurysm coiling devices (platinum coil, liquid embolic agents, and flow diversion device) and support devices (microcatheter, and microguidewire). The major players operating in Neurointerventional device market and extensively covered in this report are Covidien, PLC (Ireland), Stryker Corporation (U.S.), Johnson & Johnson (U.S.), and Penumbra, Inc. (U.S.). |
Upcoming |
|
|
Global Sleep Apnea Devices The report analyzes the market of devices in terms of 2 segments, namely such as diagnostic & therapeutic sleep apnea devices. Both these segments have experienced positive growth over the period mentioned in the report, owing to the rise in the awareness levels, among patients as well as caregiver communities. The Positive Airway Pressure (PAP) devices segment is the largest contributor to the global sleep apnea therapeutic devices market. |
Apr 2016 |
|
|
Payment Link Hematology Market Study Payment Link Hematology Market Study |
Upcoming |
|
|
Coagulation The hematology market is assessed as a mature market and is characterized by intense competition with a high demand for clinical coagulation tests. The coagulation market can be segmented by geographies, end users, companies, and macro indicators. A deep-dive analysis of the top players of this market has been provided in this report. |
Upcoming |
|
|
Clinical Chemistry The global clinical chemistry market was valued at $10.3 Billion in 2013 and is growing at a CAGR of 8.3%. The market can be segmented by geographies, end users, companies, and macro indicators. A deep-dive analysis of the top players of this market has been provided in this report. |
Upcoming |
|
|
Immunoassay Global Immunoassay Market forecast is pegged at $12.5 Billion in 2013 and growing at a CAGR of 8.5%. Global Immunoassay Market can be segmented by Geographies, Products, Endusers, Companies and MacroIndicators. Deep dive analysis of the top players of this market have been considered in this report. |
Upcoming |
|
|
Microbiology In 2013, the microbiology testing market was 5% to the Global IVD Market and contributed $3556.7 million in 2013 to the IVD market and is estimated to reach $4737.2 million by 2018, at a CAGR of 6.2% from 2013 to 2018. The report “Global Microbiology Market forecast for 2018 “analyzes the market by two segments such as instruments and reagents. |
Upcoming |
|
|
Molecular Diagnostics The report “Global Molecular Diagnostics Market forecast for 2018 “analyzes the market by 2 segments such as instruments and reagents. These two segments experienced a positive growth till 2013, with a market value of $4.95 Billion, Comprises of $4.17 Billion for reagents and $0.77 Billion for instruments and growing at a CAGR of 10.2%. |
Upcoming |
|
|
Instruments The IVD Instruments market is expanding, consolidating, and becoming highly competitive with a myriad of opportunities for various new instruments, reagents, calibrators, and other systems. The report “Global IVD Instruments Market forecast for 2018 “analyzes the market by 3 segments such as high risk and risk devices, devices for self testing and other devices. |
Upcoming |
infertility Treatment
